Bryan Wahl, General Counsel at Tarsus Pharmaceuticals, Inc. (TARS), sold 1,078 shares at $12.89 ($14K) on 2023-03-21, disclosed to the SEC on 2023-03-23.
Open-market sale of $14k TARS by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.89 | 350 | $5K | 33.3% |
| 2 | $12.64 | 357 | $5K | 33.3% |
| 3 | $12.15 | 371 | $5K | 33.3% |
| Total | $12.55 avg | 1,078 | $14K | 100% |
| Filing → |
| TARS | SELL | 2024-03-19 | $271K | — | Filing → |
| TARS | SELL | 2023-12-01 | $273K | — | Filing → |
| TARS | SELL | 2023-03-21 | $9K | — | Filing → |